Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
AT-02 for Amyloidosis
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial studies the long-term effects of AT-02 on people with systemic amyloidosis. It looks at safety, tolerability, and how well it works.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.